PDPN and cancer: In the presence of cancer cells, pancreatic stellate cells acquire an increased contractile ability which promotes the expression of α-smooth muscle actin (α-SMA), podoplanin and the loss of their characteristic cytoplasmic lipid droplets which results in the pathological release of extracellular matrix proteins triggering fibrosis and building a “wall” for therapy delivery (4).